Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson’s Disease: A Systemic Review
To move from the current heterogeneous dataset towards clinically relevant biomarkers and the identification of putative therapeutic targets, recommendations are derived from the limitations of the available studies to increase the future comparability of microbiome studies in PD. In addition, integration of currently available data on the gut microbiome in PD is proposed to identify […]